Results 1 to 10 of about 1,122,733 (261)

Evaluation and follow-up of antibody formation after CoronaVac vaccine. [PDF]

Rev Assoc Med Bras (1992), 2022
Çalişir B, Çöplü N, Yasar-Duman M, Kilinc C, Ozbek R, Demir C, Ergül Z.   +6 more
europepmc   +1 more source

New Human Leukocyte Antigen (HLA) Antibody Formation and Creatinine Elevation With Abaloparatide in Kidney Transplant Recipient. [PDF]

JBMR Plus, 2023
Swanson CM, Krohn K, Wiseman A, Rothman MS.   +3 more
europepmc   +1 more source

Pharmacological Characterization of a Novel Complement C3 Inhibitor Antibody Fragment

Ophthalmology and Therapy
Introduction The complement system is a key driver of geographic atrophy (GA), a disease that leads to progressive, irreversible vision loss. Pharmacological preclinical studies characterizing an antibody fragment, which is a novel complement C3 ...
Stephanie Jungmichel, Stefan Kreideweiß, Fabian Scheifele, Anna Sobieraj, Philipp Richle, Pankaj Gupta, Daniel Lenherr-Frey, Remko A. Bakker, Leonardo Borras   +8 more
doaj   +1 more source

Effects of the complement system on antibody formation and function: implications for transplantation. [PDF]

Curr Opin Organ Transplant, 2022
Cumpelik A, Heeger PS.
europepmc   +1 more source

Antibody Formation in Myelomatosis [PDF]

Journal of Clinical Pathology, 1953
openaire   +2 more sources

Efficacy of Accelerated Vaccination against Hbv to Achieve Antibody formation in Multiple Sclerosis Patients Receiving Anti-Cd20 Therapy. [PDF]

Ann Indian Acad Neurol, 2023
Koc ER, Turan OF, Saridas F, Menguc B, Minaz SN, Ozkaya G.   +5 more
europepmc   +1 more source

Effect of Tocilizumab Treatment on Seroconversion in Hyperinflammation Secondary to Covid 19

Acta Medica Alanya
Aim:During the ongoing COVID-19 pandemic, the management of hyperinflammation, a serious symptom that occurs secondary to the disease, has emerged as a major challenge. Tocilizumab, an immunosuppressive drug, offers a potential solution.
Nilgün Işıksaçan, Hakan Koçoğlu, Ezgi Şahin, Deniz Yılmaz, Faruk Karandere, Felemez Arslan   +5 more
doaj   +1 more source

Oral tolerance to prevent anti-drug antibody formation in protein replacement therapies. [PDF]

Cell Immunol, 2022
Rana J, Muñoz MM, Biswas M.
europepmc   +1 more source

Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX^®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. [PDF]

Toxins (Basel), 2023
Jankovic J, Carruthers J, Naumann M, Ogilvie P, Boodhoo T, Attar M, Gupta S, Singh R, Soliman J, Yushmanova I, Brin MF, Shen J.   +11 more
europepmc   +1 more source

A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination. [PDF]

Vaccine, 2023
Augustyniak A, Szymański T, Porzucek F, Mieloch AA, Semba JA, Hubert KA, Grajek D, Krela R, Rogalska Z, Zalc-Budziszewska E, Wysocki S, Sobczak K, Kuczyński L, Rybka JD.   +13 more
europepmc   +1 more source